Search

everythinglearnresearchcommunity

for

Search:↓

Midscalp hair density and terminal hair percentage are good indicators of female pattern hair loss severity.

Different types of female pattern hair loss have unique characteristics and are associated with various health conditions.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

Male pattern baldness is often genetic and linked to a hormone, with treatments like finasteride and minoxidil being effective for some men.

Baldness may lower the risk of testicular cancer.

Researchers found a new gene area linked to male-pattern baldness, which, along with another gene, significantly increases the risk of hair loss in men.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Severe baldness on the top of the head is linked to a higher chance of heart disease, especially in men under 60.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Hair loss causes differ between men and women due to changes in hormone levels and inflammation-related pathways.

Minoxidil, when applied to the scalp, can stimulate hair growth but effects vary, stop if treatment ends, and it may cause side effects like fluid retention.

Genetic factors can help predict male pattern baldness risk.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

AR polyglycine repeat doesn't cause baldness.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

A gene called HDAC9 might be a new factor in male-pattern baldness.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

A specific genetic mutation may increase male pattern baldness risk, especially in Europeans.

Men with male pattern baldness have a higher risk of certain skin cancers, especially on the scalp.

WNT10A and EBF1 interaction affects hair growth in male-pattern baldness.

Male-pattern baldness is weakly linked to some heart disease risk factors but not a strong indicator for heart disease.

The conclusion is that there's no significant link between male pattern baldness and the severity of coronary artery disease.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Early-stage skin cells help regenerate hair follicles, with proteins SDF1, MMP3, biglycan, and LTBP1 playing key roles.